BioScrip to Host First Quarter 2009 Earnings Call

ELMSFORD, N.Y.--(Business Wire)--
BioScrip, Inc. (Nasdaq: BIOS) announced today that it will release its first
quarter 2009 financial results before the market opens on Thursday, April 30th,
and host a conference call shortly thereafter at 9:00 AM (Eastern Time) to
discuss the results. Richard H. Friedman, Chairman and Chief Executive Officer,
Stanley G. Rosenbaum, Executive Vice President and Chief Financial Officer, and
Richard M. Smith, President and Chief Operating Officer, will host the call.

Interested parties may participate in the conference call by dialing
866-740-0378 (US), or 706-679-9096 (International), 5-10 minutes prior to the
start of the call. A replay of the conference call will be available from 12:00
p.m. Eastern Time on Thursday, April 30, through 12:00 p.m. Eastern Time on May
14, by dialing 800-633-8284 (US), or 402-977-9140 (International), and entering
reservation #21422586. An audio web cast and archive of the conference call will
also be available under the investor relations section of the BioScrip website
at www.bioscrip.com.

About BioScrip, Inc.

BioScrip, Inc. is a specialty pharmaceutical healthcare organization that
partners with patients, physicians, healthcare payors and pharmaceutical
manufacturers to provide access to medications and management solutions to
optimize outcomes for chronic and other complex healthcare conditions.

Forward Looking Statements

This press release may contain statements which constitute forward looking
statements within the meaning of the Private Securities Litigation Reform Act of
1995, including statements regarding the intent, belief or current expectations
of the Company, its directors, or its officers with respect to the future
operating performance of the Company and our success with respect to the
integration and consolidation. Investors are cautioned that any such forward
looking statements are not guarantees of future performance and involve risks
and uncertainties, and that actual results may differ materially from those in
the forward looking statements as a result of various factors. Important factors
that could cause such differences are described in the Company's periodic
filings with the Securities and Exchange Commission.

In-Site Communications, Inc.
Lisa M. Wilson, 917-543-9932
lwilson@insitecony.com
or
BioScrip, Inc.
Stanley G. Rosenbaum, 952-979-3768
EVP, Chief Financial Officer
srosenbaum@bioscrip.com

Copyright Business Wire 2009